Applied BioSciences(APPB)
$0.000.00 (0.00%)
APPB
Applied BioSciences financials statements
$0.00
At close:0.00 (0.00%)
Applied BioSciences (APPB) Ratios
50 Followers
Applied BioSciences Ratios
APPB's free cash flow for Q3 2020 was $-52.14K. For the 2020 fiscal year, APPB's free cash flow was increased by $0.00 and operating cash flow was $-52.14K. See a summary of the company’s cash flow.
| Ratios | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.01 | 0.20 | 0.95 | 6.32 | 8.17 |
| Quick Ratio | 0.01 | 0.16 | 0.74 | 5.51 | 7.45 |
| Cash Ratio | 0.00 | 0.15 | 0.13 | 1.70 | 6.73 |
| Solvency Ratio | -0.70 | -1.16 | -6.92 | -59.95 | -15.76 |
| Operating Cash Flow Ratio | -1.09 | -0.35 | -2.42 | -18.77 | -4.78 |
| Short-Term Operating Cash Flow Coverage | -6.77 | -3.40 | -36.20 | 0.00 | 0.00 |
| Net Current Asset Value | $ -841.41K | $ -3.14M | $ -19.81K | $ 190.96K | $ 226.35K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.12 | 0.01 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | -0.94 | -0.29 | 0.01 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | -14.82 | -0.40 | 0.01 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -4.39 | -2.50 | 1.71 | 1.04 | 1.02 |
| Debt Service Coverage Ratio | -6.55 | -2.73 | -2.95 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | -3.06 | -4.08 | 0.00 | 0.00 |
| Debt to Market Cap | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.10 | 0.06 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.38 | 0.04 | 0.01 | 0.03 | 1.78 |
| Profitability Margins | |||||
| Gross Profit Margin | -358.52% | 39.65% | 26.21% | 21.26% | 85.97% |
| EBIT Margin | -1014.68% | -547.05% | -287.12% | -1208.21% | -306.35% |
| EBITDA Margin | -817.88% | -518.85% | -281.38% | -1094.43% | -262.54% |
| Operating Profit Margin | -781.32% | -427.13% | -374.27% | -303.48% | -1132.55% |
| Pretax Profit Margin | -1014.68% | -686.49% | -378.89% | -1208.21% | -1132.55% |
| Net Profit Margin | -865.30% | -646.10% | -371.87% | -1202.76% | -1136.36% |
| Continuous Operations Profit Margin | -1014.68% | -686.49% | -378.89% | -1208.21% | -1132.55% |
| Net Income Per EBT | 85.28% | 94.12% | 98.15% | 99.55% | 100.34% |
| EBT Per EBIT | 129.87% | 160.72% | 101.24% | 398.12% | 100.00% |
| Return on Assets (ROA) | -60.06% | -139.35% | -72.01% | -336.88% | -30.88% |
| Return on Equity (ROE) | 263.60% | 347.98% | -123.16% | -350.22% | -31.51% |
| Return on Capital Employed (ROCE) | -117.71% | 1331.12% | -80.75% | -89.56% | -31.37% |
| Return on Invested Capital (ROIC) | -99.07% | -2325.52% | -80.14% | -89.56% | -31.37% |
| Return on Tangible Assets | -81.95% | -244.34% | -153.73% | -336.88% | -92.78% |
| Earnings Yield | -27.99% | -4.26% | -1.66% | -0.79% | -0.20% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 16.03 | 4.33 | 15.95 | 8.02 |
| Payables Turnover | 0.84 | 0.68 | 2.21 | 7.12 | 0.52 |
| Inventory Turnover | 0.00 | 3.42 | 6.63 | 5.35 | 0.28 |
| Fixed Asset Turnover | 0.25 | 1.16 | 1.56 | 44.48 | 0.00 |
| Asset Turnover | 0.07 | 0.22 | 0.19 | 0.28 | 0.03 |
| Working Capital Turnover Ratio | -0.05 | -0.50 | 8.26 | 0.95 | 0.49 |
| Cash Conversion Cycle | -433.10 | -404.81 | -26.02 | 39.85 | 639.56 |
| Days of Sales Outstanding | 0.00 | 22.77 | 84.35 | 22.88 | 45.49 |
| Days of Inventory Outstanding | 0.00 | 106.82 | 55.08 | 68.22 | 1296.38 |
| Days of Payables Outstanding | 433.10 | 534.40 | 165.45 | 51.26 | 702.30 |
| Operating Cycle | 0.00 | 129.58 | 139.43 | 91.11 | 1341.86 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.05 | -0.09 | -0.08 | -0.04 | -0.01 |
| Free Cash Flow Per Share | -0.05 | -0.09 | -0.08 | -0.04 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | -187428.50 | -975.39 | -582.03 | -143.32 | -1.01 |
| Capital Expenditure Coverage Ratio | -187428.50 | -975.39 | -582.03 | -143.32 | -1.01 |
| Operating Cash Flow Coverage Ratio | -2.75 | -3.21 | -36.20 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -8.46 | -1.72 | -1.28 | -3.41 | -3.31 |
| Free Cash Flow Yield | -27.35% | -1.13% | -0.57% | -0.22% | -0.12% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.57 | -23.46 | -60.18 | -126.86 | -488.70 |
| Price-to-Sales (P/S) Ratio | 30.92 | 151.58 | 223.78 | 1525.80 | 5553.40 |
| Price-to-Book (P/B) Ratio | -9.42 | -81.64 | 74.11 | 444.28 | 153.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.66 | -88.15 | -174.52 | -444.48 | -840.92 |
| Price-to-Operating Cash Flow Ratio | -3.66 | -88.24 | -174.82 | -447.58 | -1677.19 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | -0.43 | -1.60 | -0.47 | -0.34 |
| Enterprise Value Multiple | -4.16 | -29.18 | -79.52 | -139.39 | -2113.47 |
| Enterprise Value | 3.01M | 109.51M | 158.20M | 301.37M | 252.77M |
| EV to EBITDA | -4.16 | -29.18 | -79.52 | -139.39 | -2113.47 |
| EV to Sales | 33.99 | 151.39 | 223.75 | 1525.49 | 5548.73 |
| EV to Free Cash Flow | -4.02 | -88.04 | -174.50 | -444.39 | -840.22 |
| EV to Operating Cash Flow | -4.02 | -88.13 | -174.80 | -447.49 | -1675.78 |
| Tangible Book Value Per Share | 0.01 | -0.14 | 0.11 | 0.04 | 0.04 |
| Shareholders’ Equity Per Share | -0.02 | -0.10 | 0.18 | 0.05 | 0.14 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.37 | -0.73 |
| Revenue Per Share | 0.01 | 0.05 | 0.06 | 0.01 | 0.00 |
| Net Income Per Share | -0.06 | -0.34 | -0.22 | -0.16 | -0.04 |
| Tax Burden | 0.85 | 0.94 | 0.98 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.25 | 1.32 | 1.00 | 3.70 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 2.96 | 4.83 | 3.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 1.50 | 0.00 | 0.00 |
| Income Quality | 0.98 | 0.27 | 0.34 | 0.28 | 0.29 |
Currency in USD
